Company Name | Date | Purpose |
---|---|---|
Vivo Bio Tech | 30-May-2023 | VIVO BIO TECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 inter alia to consider and approve Audited Standalone and Consolidated Financial Results for the Fourth Quarter and Year Ended March 31 2023 |
Sahara Housing | 30-May-2023 | SAHARA HOUSINGFINA CORPORATION LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 inter alia to consider and approve This is to inform that a meeting of the Board of Directors of the Company will be held on Tuesday 30th May 2023 to consider inter alia the Audited Financial Results for the year ended 31st March 2023. |
Pro Fin Capital | 30-May-2023 | PRO FIN CAPITAL SERVICES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 inter alia to consider and approve Notice of the Board Meeting to consider Audited Results for the Year ended March 31 2023. |
Avonmore Capital | 30-May-2023 | Avonmore Capital & Management Services Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 inter alia to consider and approve In pursuance of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 Notice is hereby given that a Meeting of the Board of Directors of the Company is scheduled to be held on Tuesday the 30th May 2023 inter alia to consider and approve the Audited Financial Results (Standalone as well as Consolidated) for the Quarter and Financial Year ended 31st March2023 and to consider and take on record Annual Accounts for the Financial Year 2022-23. The said Notice is also available at Companys website at www.avonmorecapital.in You are requested to kindly take the same on your record. |
IM+ Capitals | 30-May-2023 | IM+ Capitals Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 inter alia to consider and approve Pursuant to Regulation 29(1)(a) Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (the said Regulations) this is to inform you that as required under Regulation 33 read in conjunction with Regulation 52 of the said Regulations Notice is hereby given that meeting of Board of directors of the Company is scheduled to be held on Tuesday 30th May 2023 at the Registered office of the Company at 72 Ground Floor World Trade Center Babar Road Connaught Place New Delhi 110001 interalia to consider & approve audited financial results for the fourth quarter & year ended 31st March 2023. |
Nettlinx | 30-May-2023 | NETTLINX LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 inter alia to consider and approve the standalone and consolidated Audited Financial Results for the Quarter and Year ended 31.03.2023 and for approval of other items. |
BGIL Films & Tec | 30-May-2023 | BGIL FILMS & TECHNOLOGIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 inter alia to consider and approve PFA |
IFL Promoters | 30-May-2023 | IFL PROMOTERS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 inter alia to consider and approve Intimation for the approval of Audited Financial Results Quarter/ Financial Year ended 31st March 2023 along with Auditors Report is attached. |
Warner Multi. | 30-May-2023 | WARNER MULTIMEDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 inter alia to consider and approve Audited Financial Results for the 4th quarter ended on 31st March 2023 for the Financial Year ended on 31st March 2023. |
Relic Tech. | 30-May-2023 | RELIC TECHNOLOGIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 inter alia to consider and approve Relic Technologies LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 inter alia to consider and approve Standalone and Consolidated Audited Financial Results Of The Company For The Quarter And Year Ended March 31 2023 |